Figure 4
Quercitrin increased the osteoblastic differentiation of hMSCs.
(A) ALP activity and (B) calcium content determined after 19 days of hMSCs growth under six different conditions: basal media; basal media with 200 μM quercitrin (QUER); osteogenic media (OS); osteogenic media with 200 μM quercitrin; osteogenic media supplemented with interleukin-1 beta (IL-1β); and osteogenic media supplemented with IL-1β and quercitrin. Values represent the mean ± SEM of two independent experiments. One, two and three symbols represent a significant difference between two groups with P ≤ 0.05, P < 0.01 and P < 0.001, respectively: (*) treatment versus control (vehicle); (#) quercitrin versus vehicle; (§) inflammation groups versus osteogenic groups.
